MX2022012128A - Comprimido complejo oral que comprende sitagliptina, dapagliflozina y metformina. - Google Patents

Comprimido complejo oral que comprende sitagliptina, dapagliflozina y metformina.

Info

Publication number
MX2022012128A
MX2022012128A MX2022012128A MX2022012128A MX2022012128A MX 2022012128 A MX2022012128 A MX 2022012128A MX 2022012128 A MX2022012128 A MX 2022012128A MX 2022012128 A MX2022012128 A MX 2022012128A MX 2022012128 A MX2022012128 A MX 2022012128A
Authority
MX
Mexico
Prior art keywords
dapagliflozin
sitagliptin
metformin
complex tablet
pharmaceutically acceptable
Prior art date
Application number
MX2022012128A
Other languages
English (en)
Inventor
Taek Kwan Kwon
Ho Taek Im
Jin Wook Tak
Bo Sik Kim
Yong Il Kim
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of MX2022012128A publication Critical patent/MX2022012128A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

De acuerdo con un aspecto, se proporcionan un comprimido compuesto y un método de preparación del comprimido compuesto, en donde el comprimido compuesto puede incluir una primera capa que incluye gránulos secos que incluyen sitagliptina o una sal farmacéuticamente aceptable de la misma, o, un hidrato de la misma, y dapagliflozina o una sal farmacéuticamente aceptable de la misma, o un hidrato de la misma, y una segunda capa que incluye gránulos húmedos que incluyen metformina o una sal farmacéuticamente aceptable de la misma y dióxido de silicio coloidal.
MX2022012128A 2020-03-30 2021-03-12 Comprimido complejo oral que comprende sitagliptina, dapagliflozina y metformina. MX2022012128A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200038568A KR20210121599A (ko) 2020-03-30 2020-03-30 시타글립틴, 다파글리플로진, 및 메트포르민을 포함하는 경구용 복합정제
PCT/KR2021/003080 WO2021201461A1 (ko) 2020-03-30 2021-03-12 시타글립틴, 다파글리플로진, 및 메트포르민을 포함하는 경구용 복합정제

Publications (1)

Publication Number Publication Date
MX2022012128A true MX2022012128A (es) 2022-10-18

Family

ID=77929083

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012128A MX2022012128A (es) 2020-03-30 2021-03-12 Comprimido complejo oral que comprende sitagliptina, dapagliflozina y metformina.

Country Status (9)

Country Link
US (1) US20230149314A1 (es)
EP (1) EP4112047A4 (es)
JP (1) JP2023519532A (es)
KR (1) KR20210121599A (es)
CN (1) CN115297847A (es)
AU (1) AU2021249767A1 (es)
BR (1) BR112022019539A2 (es)
MX (1) MX2022012128A (es)
WO (1) WO2021201461A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220007446A (ko) * 2020-07-10 2022-01-18 한미약품 주식회사 시타글립틴 및 다파글리플로진을 포함하는 복합제제 및 그 제조방법
EP4212150A1 (en) * 2022-01-13 2023-07-19 Sanovel Ilac Sanayi Ve Ticaret A.S. A bilayer tablet composition comprising amorphous dapagliflozin and metformin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20180109A1 (ar) * 2005-09-29 2019-01-30 Novartis Ag تركيبة جديدة
PT2498758T (pt) * 2009-11-13 2018-10-23 Astrazeneca Uk Ltd Formulações de comprimido bicamada
WO2013110085A1 (en) * 2012-01-20 2013-07-25 Handa Pharmaceuticals, Llc Oral dosage forms for delivering metformin and sitagliptin
KR20160111237A (ko) * 2015-03-16 2016-09-26 한미약품 주식회사 메트포르민 및 시타글립틴을 포함하는 경구용 복합제제
WO2018124497A1 (ko) * 2016-12-30 2018-07-05 한미약품 주식회사 다파글리플로진 l-프롤린과 항당뇨병제를 포함하는 약제학적 복합 제제
KR102369679B1 (ko) * 2017-09-29 2022-03-04 한미약품 주식회사 다파글리플로진 l-프롤린과 메트포르민을 포함하는 약제학적 복합제제
KR102204439B1 (ko) * 2018-05-14 2021-01-18 에이치케이이노엔 주식회사 Sglt-2 억제제 및 dpp-iv 억제제를 포함하는 약제학적 조성물

Also Published As

Publication number Publication date
EP4112047A4 (en) 2024-03-27
EP4112047A1 (en) 2023-01-04
CN115297847A (zh) 2022-11-04
JP2023519532A (ja) 2023-05-11
AU2021249767A1 (en) 2022-09-22
KR20210121599A (ko) 2021-10-08
WO2021201461A1 (ko) 2021-10-07
BR112022019539A2 (pt) 2022-11-16
US20230149314A1 (en) 2023-05-18

Similar Documents

Publication Publication Date Title
MX2022012128A (es) Comprimido complejo oral que comprende sitagliptina, dapagliflozina y metformina.
USD887487S1 (en) Typeface
NL301104I2 (nl) Fedratinib, of een farmaceutisch aanvaardbaar zout daarvan, of een farmaceutisch aanvaardbaar hydraat daarvan, in het bijzonder fedratinibdihydrochloridemonohydraat.
UA88477C2 (ru) Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
TWI347850B (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
CA3018932C (en) Pharmaceutical combinations for the treatment of cancer
TWD181303S (zh) 晶圓載具
WO2007061737A3 (en) FUSED BICYCLIC mTOR INHIBITORS
USD919837S1 (en) Privacy booth
TWD181302S (zh) 晶圓載具
MX2019007339A (es) Compuestos de pirazolopirimidina y metodos de uso de los mismos.
MY136901A (en) Water-soluble meloxicam granules
GB201814192D0 (en) A semiconductor on diamond substrate, percursor for use in preparing a semiconductor on diamond substrate, and methods of making the same
MX2020005771A (es) Composicion y metodo para tratar el linfoma periferico de linfocitos t y el linfoma cutaneo de linfocitos t.
USD866877S1 (en) Horseshoe
WO2006085168A3 (en) Solid oral dosage forms of ziprasidone containing colloidal silicone dioxide
MX2022011711A (es) Compuesto de oxofenilarsina deuterada y uso del mismo.
WO2018085216A8 (en) 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
EP3970793A4 (en) AGENT FOR THE PREVENTION, APPEAL OR TREATMENT OF PERIODONTAL DISEASE
MX2023008016A (es) Tasquinimod o una sal farmaceutica aceptable para su uso en el tratamiento del sindrome mielodisplasico.
MX2020013352A (es) Tratamiento para migrañas.
WO2021015294A3 (en) Combination therapy for cancer treatment
TW200631506A (en) Granules of hydrophilic active principle
PH12021550572A1 (en) Novel thiazole derivatives and pharmaceutically acceptable salts thereof
AP2004003193A0 (en) Microcapsules for the delayed, controlled relese of perindopril.